The global Neurostimulation Devices market size is estimated to be worth US$ 7454.1 million in 2022 and is forecast to a readjusted size of US$ 14170 million by 2028 with a CAGR of 11.3% during the review period. Key drivers of the neurostimulation devices market include the growing number of neurological disorders such as Parkinson’s disease, Epilepsy, depression, chronic pain, etc. The rise in the geriatric population is also contributing to the market expansion. The increasing R&D initiatives for developing technologically advanced devices and increasing trends for minimally invasive surgeries, drug-free treatment, and therapeutic potential are expected to propel the neurostimulation devices market in the coming years.
Increasing geriatric population and the growing number of neurological disorders
The geriatric population is growing due to the rapid extension of life expectancy around the world. Prolonged aging has increased the occurrence of several non-communicable, chronic, and progressive diseases. Neurological disorders such as Dementia, Epilepsy, Stroke, Parkinson's disease, Depression, etc are becoming common across the entire globe. The frequency and severity of these diseases have also risen leading to a reduction in the quality of life of the patients. Thus growing nerve disorders is augmenting the need for neurostimulation methods thereby accelerating the neurostimulation devices market during the review period.
R&D initiatives for new developments and the growing popularity of minimally invasive surgery
The growing research and development initiatives for advanced neurostimulation technology devices along with a better understanding of neurocircuitry, neuroimaging has increased the use of these devices for providing therapeutic relief to patients suffering from a wide range of mental health diseases. Further, the growing preference for minimally invasive surgeries and drug-free treatments has also contributed to the growth. Thus the above-mentioned factors are expected to surge the neurostimulation devices market expansion in the coming years.
Based on region, North America is expected to dominate the neurostimulation devices market share with 40% followed by China, Europe with a total share of 40%. North America will grow due to quick approvals and the development of innovative technologies.
Based on type, Spinal Cord Stimulation is expected to provide lucrative opportunities for growth in the Neurostimulation Devices market share with 55% due to large scale product application and increasing market penetration.
Based on application, the pain management segment is expected to provide ample opportunities for growth in the neurostimulation devices market share due to rising chronic pain diseases and extensive use of these devices for pain management.
| Report Metric | Details |
| Report Name | Neurostimulation Devices Market |
| The market size in 2022 | USD 7454.1 Million |
| The revenue forecast in 2028 | USD 14170 Million |
| Growth Rate | Compound Annual Growth Rate (CAGR) of 11.3% from 2022 to 2028 |
| Market size available for years | 2022-2028 |
| Forecast units | Value (USD) |
| Segments covered | Type, Application & Regions |
| Report coverage | Revenue & volume forecast, company share, competitive landscape, growth factors, and trends |
| Geographic regions covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Ans. The global Neurostimulation Devices market size is estimated to be worth US$ 7454.1 million in 2022 and is forecast to a readjusted size of US$ 14170 million by 2028.
Ans. The global Neurostimulation Devices market is expected to grow at a compound annual growth rate of 11.3% from 2022 to 2028.
Ans. Some of the major companies are Medtronic, Boston Scientific, Abbott, LivaNova, Nevro, NeuroPace, Beijing Pins, Synapse Biomedical.
Table of Contents
1 Study Coverage
1.1 Neurostimulation Devices Product Introduction
1.2 Market by Type
1.2.1 Global Neurostimulation Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Spinal Cord Stimulation (SCS)
1.2.3 Gastric Electric Stimulation (GES)
1.2.4 Deep Brain Stimulation (DBS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Vagus Nerve Stimulation (VNS)
1.2.7 Other
1.3 Market by Application
1.3.1 Global Neurostimulation Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pain Management
1.3.3 Parkinson’s Disease
1.3.4 Urinary and Fecal Incontinence
1.3.5 Epilepsy
1.3.6 Gastroparesis
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neurostimulation Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Neurostimulation Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Neurostimulation Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Neurostimulation Devices Sales by Region
2.4.1 Global Neurostimulation Devices Sales by Region (2017-2022)
2.4.2 Global Sales Neurostimulation Devices by Region (2023-2028)
2.5 Global Neurostimulation Devices Revenue by Region
2.5.1 Global Neurostimulation Devices Revenue by Region (2017-2022)
2.5.2 Global Neurostimulation Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neurostimulation Devices Sales by Manufacturers
3.1.1 Global Top Neurostimulation Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Neurostimulation Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurostimulation Devices in 2021
3.2 Global Neurostimulation Devices Revenue by Manufacturers
3.2.1 Global Neurostimulation Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Neurostimulation Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Neurostimulation Devices Revenue in 2021
3.3 Global Neurostimulation Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neurostimulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neurostimulation Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neurostimulation Devices Sales by Type
4.1.1 Global Neurostimulation Devices Historical Sales by Type (2017-2022)
4.1.2 Global Neurostimulation Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Neurostimulation Devices Sales Market Share by Type (2017-2028)
4.2 Global Neurostimulation Devices Revenue by Type
4.2.1 Global Neurostimulation Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Neurostimulation Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Neurostimulation Devices Revenue Market Share by Type (2017-2028)
4.3 Global Neurostimulation Devices Price by Type
4.3.1 Global Neurostimulation Devices Price by Type (2017-2022)
4.3.2 Global Neurostimulation Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Neurostimulation Devices Sales by Application
5.1.1 Global Neurostimulation Devices Historical Sales by Application (2017-2022)
5.1.2 Global Neurostimulation Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Neurostimulation Devices Sales Market Share by Application (2017-2028)
5.2 Global Neurostimulation Devices Revenue by Application
5.2.1 Global Neurostimulation Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Neurostimulation Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Neurostimulation Devices Revenue Market Share by Application (2017-2028)
5.3 Global Neurostimulation Devices Price by Application
5.3.1 Global Neurostimulation Devices Price by Application (2017-2022)
5.3.2 Global Neurostimulation Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Neurostimulation Devices Market Size by Type
6.1.1 North America Neurostimulation Devices Sales by Type (2017-2028)
6.1.2 North America Neurostimulation Devices Revenue by Type (2017-2028)
6.2 North America Neurostimulation Devices Market Size by Application
6.2.1 North America Neurostimulation Devices Sales by Application (2017-2028)
6.2.2 North America Neurostimulation Devices Revenue by Application (2017-2028)
6.3 North America Neurostimulation Devices Market Size by Country
6.3.1 North America Neurostimulation Devices Sales by Country (2017-2028)
6.3.2 North America Neurostimulation Devices Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Neurostimulation Devices Market Size by Type
7.1.1 Europe Neurostimulation Devices Sales by Type (2017-2028)
7.1.2 Europe Neurostimulation Devices Revenue by Type (2017-2028)
7.2 Europe Neurostimulation Devices Market Size by Application
7.2.1 Europe Neurostimulation Devices Sales by Application (2017-2028)
7.2.2 Europe Neurostimulation Devices Revenue by Application (2017-2028)
7.3 Europe Neurostimulation Devices Market Size by Country
7.3.1 Europe Neurostimulation Devices Sales by Country (2017-2028)
7.3.2 Europe Neurostimulation Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neurostimulation Devices Market Size by Type
8.1.1 Asia Pacific Neurostimulation Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Neurostimulation Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Neurostimulation Devices Market Size by Application
8.2.1 Asia Pacific Neurostimulation Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Neurostimulation Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Neurostimulation Devices Market Size by Region
8.3.1 Asia Pacific Neurostimulation Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Neurostimulation Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Neurostimulation Devices Market Size by Type
9.1.1 Latin America Neurostimulation Devices Sales by Type (2017-2028)
9.1.2 Latin America Neurostimulation Devices Revenue by Type (2017-2028)
9.2 Latin America Neurostimulation Devices Market Size by Application
9.2.1 Latin America Neurostimulation Devices Sales by Application (2017-2028)
9.2.2 Latin America Neurostimulation Devices Revenue by Application (2017-2028)
9.3 Latin America Neurostimulation Devices Market Size by Country
9.3.1 Latin America Neurostimulation Devices Sales by Country (2017-2028)
9.3.2 Latin America Neurostimulation Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neurostimulation Devices Market Size by Type
10.1.1 Middle East and Africa Neurostimulation Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Neurostimulation Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Neurostimulation Devices Market Size by Application
10.2.1 Middle East and Africa Neurostimulation Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Neurostimulation Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Neurostimulation Devices Market Size by Country
10.3.1 Middle East and Africa Neurostimulation Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Neurostimulation Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Medtronic Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Overview
11.2.3 Boston Scientific Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Boston Scientific Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boston Scientific Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 LivaNova
11.4.1 LivaNova Corporation Information
11.4.2 LivaNova Overview
11.4.3 LivaNova Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 LivaNova Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LivaNova Recent Developments
11.5 Nevro
11.5.1 Nevro Corporation Information
11.5.2 Nevro Overview
11.5.3 Nevro Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Nevro Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Nevro Recent Developments
11.6 NeuroPace
11.6.1 NeuroPace Corporation Information
11.6.2 NeuroPace Overview
11.6.3 NeuroPace Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 NeuroPace Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 NeuroPace Recent Developments
11.7 Beijing Pins
11.7.1 Beijing Pins Corporation Information
11.7.2 Beijing Pins Overview
11.7.3 Beijing Pins Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Beijing Pins Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beijing Pins Recent Developments
11.8 Synapse Biomedical
11.8.1 Synapse Biomedical Corporation Information
11.8.2 Synapse Biomedical Overview
11.8.3 Synapse Biomedical Neurostimulation Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Synapse Biomedical Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Synapse Biomedical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neurostimulation Devices Industry Chain Analysis
12.2 Neurostimulation Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurostimulation Devices Production Mode & Process
12.4 Neurostimulation Devices Sales and Marketing
12.4.1 Neurostimulation Devices Sales Channels
12.4.2 Neurostimulation Devices Distributors
12.5 Neurostimulation Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neurostimulation Devices Industry Trends
13.2 Neurostimulation Devices Market Drivers
13.3 Neurostimulation Devices Market Challenges
13.4 Neurostimulation Devices Market Restraints
14 Key Findings in The Global Neurostimulation Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Neurostimulation Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Spinal Cord Stimulation (SCS)
Table 3. Major Manufacturers of Gastric Electric Stimulation (GES)
Table 4. Major Manufacturers of Deep Brain Stimulation (DBS)
Table 5. Major Manufacturers of Sacral Nerve Stimulation (SNS)
Table 6. Major Manufacturers of Vagus Nerve Stimulation (VNS)
Table 7. Major Manufacturers of Other
Table 8. Global Neurostimulation Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Neurostimulation Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Neurostimulation Devices Sales by Region (2017-2022) & (Units)
Table 11. Global Neurostimulation Devices Sales Market Share by Region (2017-2022)
Table 12. Global Neurostimulation Devices Sales by Region (2023-2028) & (Units)
Table 13. Global Neurostimulation Devices Sales Market Share by Region (2023-2028)
Table 14. Global Neurostimulation Devices Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Neurostimulation Devices Revenue Market Share by Region (2017-2022)
Table 16. Global Neurostimulation Devices Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Neurostimulation Devices Revenue Market Share by Region (2023-2028)
Table 18. Global Neurostimulation Devices Sales by Manufacturers (2017-2022) & (Units)
Table 19. Global Neurostimulation Devices Sales Share by Manufacturers (2017-2022)
Table 20. Global Neurostimulation Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Neurostimulation Devices Revenue Share by Manufacturers (2017-2022)
Table 22. Neurostimulation Devices Price by Manufacturers (2017-2022) &(USD/Unit)
Table 23. Global Neurostimulation Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Neurostimulation Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurostimulation Devices as of 2021)
Table 25. Neurostimulation Devices Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Neurostimulation Devices Product Offered
Table 27. Date of Manufacturers Enter into Neurostimulation Devices Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Neurostimulation Devices Sales by Type (2017-2022) & (Units)
Table 30. Global Neurostimulation Devices Sales by Type (2023-2028) & (Units)
Table 31. Global Neurostimulation Devices Sales Share by Type (2017-2022)
Table 32. Global Neurostimulation Devices Sales Share by Type (2023-2028)
Table 33. Global Neurostimulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Neurostimulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Neurostimulation Devices Revenue Share by Type (2017-2022)
Table 36. Global Neurostimulation Devices Revenue Share by Type (2023-2028)
Table 37. Neurostimulation Devices Price by Type (2017-2022) & (USD/Unit)
Table 38. Global Neurostimulation Devices Price Forecast by Type (2023-2028) & (USD/Unit)
Table 39. Global Neurostimulation Devices Sales by Application (2017-2022) & (Units)
Table 40. Global Neurostimulation Devices Sales by Application (2023-2028) & (Units)
Table 41. Global Neurostimulation Devices Sales Share by Application (2017-2022)
Table 42. Global Neurostimulation Devices Sales Share by Application (2023-2028)
Table 43. Global Neurostimulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Neurostimulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Neurostimulation Devices Revenue Share by Application (2017-2022)
Table 46. Global Neurostimulation Devices Revenue Share by Application (2023-2028)
Table 47. Neurostimulation Devices Price by Application (2017-2022) & (USD/Unit)
Table 48. Global Neurostimulation Devices Price Forecast by Application (2023-2028) & (USD/Unit)
Table 49. North America Neurostimulation Devices Sales by Type (2017-2022) & (Units)
Table 50. North America Neurostimulation Devices Sales by Type (2023-2028) & (Units)
Table 51. North America Neurostimulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Neurostimulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Neurostimulation Devices Sales by Application (2017-2022) & (Units)
Table 54. North America Neurostimulation Devices Sales by Application (2023-2028) & (Units)
Table 55. North America Neurostimulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Neurostimulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Neurostimulation Devices Sales by Country (2017-2022) & (Units)
Table 58. North America Neurostimulation Devices Sales by Country (2023-2028) & (Units)
Table 59. North America Neurostimulation Devices Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Neurostimulation Devices Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Neurostimulation Devices Sales by Type (2017-2022) & (Units)
Table 62. Europe Neurostimulation Devices Sales by Type (2023-2028) & (Units)
Table 63. Europe Neurostimulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Neurostimulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Neurostimulation Devices Sales by Application (2017-2022) & (Units)
Table 66. Europe Neurostimulation Devices Sales by Application (2023-2028) & (Units)
Table 67. Europe Neurostimulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Neurostimulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Neurostimulation Devices Sales by Country (2017-2022) & (Units)
Table 70. Europe Neurostimulation Devices Sales by Country (2023-2028) & (Units)
Table 71. Europe Neurostimulation Devices Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Neurostimulation Devices Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Neurostimulation Devices Sales by Type (2017-2022) & (Units)
Table 74. Asia Pacific Neurostimulation Devices Sales by Type (2023-2028) & (Units)
Table 75. Asia Pacific Neurostimulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Neurostimulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Neurostimulation Devices Sales by Application (2017-2022) & (Units)
Table 78. Asia Pacific Neurostimulation Devices Sales by Application (2023-2028) & (Units)
Table 79. Asia Pacific Neurostimulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Neurostimulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Neurostimulation Devices Sales by Region (2017-2022) & (Units)
Table 82. Asia Pacific Neurostimulation Devices Sales by Region (2023-2028) & (Units)
Table 83. Asia Pacific Neurostimulation Devices Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Neurostimulation Devices Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Neurostimulation Devices Sales by Type (2017-2022) & (Units)
Table 86. Latin America Neurostimulation Devices Sales by Type (2023-2028) & (Units)
Table 87. Latin America Neurostimulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Neurostimulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Neurostimulation Devices Sales by Application (2017-2022) & (Units)
Table 90. Latin America Neurostimulation Devices Sales by Application (2023-2028) & (Units)
Table 91. Latin America Neurostimulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Neurostimulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Neurostimulation Devices Sales by Country (2017-2022) & (Units)
Table 94. Latin America Neurostimulation Devices Sales by Country (2023-2028) & (Units)
Table 95. Latin America Neurostimulation Devices Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Neurostimulation Devices Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Neurostimulation Devices Sales by Type (2017-2022) & (Units)
Table 98. Middle East and Africa Neurostimulation Devices Sales by Type (2023-2028) & (Units)
Table 99. Middle East and Africa Neurostimulation Devices Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Neurostimulation Devices Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Neurostimulation Devices Sales by Application (2017-2022) & (Units)
Table 102. Middle East and Africa Neurostimulation Devices Sales by Application (2023-2028) & (Units)
Table 103. Middle East and Africa Neurostimulation Devices Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Neurostimulation Devices Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Neurostimulation Devices Sales by Country (2017-2022) & (Units)
Table 106. Middle East and Africa Neurostimulation Devices Sales by Country (2023-2028) & (Units)
Table 107. Middle East and Africa Neurostimulation Devices Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Neurostimulation Devices Revenue by Country (2023-2028) & (US$ Million)
Table 109. Medtronic Corporation Information
Table 110. Medtronic Description and Major Businesses
Table 111. Medtronic Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Medtronic Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Medtronic Recent Developments
Table 114. Boston Scientific Corporation Information
Table 115. Boston Scientific Description and Major Businesses
Table 116. Boston Scientific Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Boston Scientific Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Boston Scientific Recent Developments
Table 119. Abbott Corporation Information
Table 120. Abbott Description and Major Businesses
Table 121. Abbott Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Abbott Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Abbott Recent Developments
Table 124. LivaNova Corporation Information
Table 125. LivaNova Description and Major Businesses
Table 126. LivaNova Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. LivaNova Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. LivaNova Recent Developments
Table 129. Nevro Corporation Information
Table 130. Nevro Description and Major Businesses
Table 131. Nevro Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Nevro Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Nevro Recent Developments
Table 134. NeuroPace Corporation Information
Table 135. NeuroPace Description and Major Businesses
Table 136. NeuroPace Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. NeuroPace Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. NeuroPace Recent Developments
Table 139. Beijing Pins Corporation Information
Table 140. Beijing Pins Description and Major Businesses
Table 141. Beijing Pins Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Beijing Pins Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Beijing Pins Recent Developments
Table 144. Synapse Biomedical Corporation Information
Table 145. Synapse Biomedical Description and Major Businesses
Table 146. Synapse Biomedical Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Synapse Biomedical Neurostimulation Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Synapse Biomedical Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Neurostimulation Devices Distributors List
Table 152. Neurostimulation Devices Customers List
Table 153. Neurostimulation Devices Market Trends
Table 154. Neurostimulation Devices Market Drivers
Table 155. Neurostimulation Devices Market Challenges
Table 156. Neurostimulation Devices Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurostimulation Devices Product Picture
Figure 3. Global Neurostimulation Devices Market Share by Type in 2021 & 2028
Figure 3. Spinal Cord Stimulation (SCS) Product Picture
Figure 4. Gastric Electric Stimulation (GES) Product Picture
Figure 5. Deep Brain Stimulation (DBS) Product Picture
Figure 6. Sacral Nerve Stimulation (SNS) Product Picture
Figure 7. Vagus Nerve Stimulation (VNS) Product Picture
Figure 8. Other Product Picture
Figure 9. Global Neurostimulation Devices Market Share by Application in 2021 & 2028
Figure 10. Pain Management
Figure 11. Parkinson’s Disease
Figure 12. Urinary and Fecal Incontinence
Figure 13. Epilepsy
Figure 14. Gastroparesis
Figure 15. Other
Figure 16. Neurostimulation Devices Report Years Considered
Figure 17. Global Neurostimulation Devices Sales 2017-2028 (Units)
Figure 18. Global Neurostimulation Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Neurostimulation Devices Revenue 2017-2028 (US$ Million)
Figure 20. Global Neurostimulation Devices Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Neurostimulation Devices Sales Market Share by Region (2017-2022)
Figure 22. Global Neurostimulation Devices Sales Market Share by Region (2023-2028)
Figure 23. North America Neurostimulation Devices Sales YoY (2017-2028) & (Units)
Figure 24. North America Neurostimulation Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Neurostimulation Devices Sales YoY (2017-2028) & (Units)
Figure 26. Europe Neurostimulation Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Neurostimulation Devices Sales YoY (2017-2028) & (Units)
Figure 28. Asia-Pacific Neurostimulation Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Neurostimulation Devices Sales YoY (2017-2028) & (Units)
Figure 30. Latin America Neurostimulation Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Neurostimulation Devices Sales YoY (2017-2028) & (Units)
Figure 32. Middle East & Africa Neurostimulation Devices Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Neurostimulation Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Neurostimulation Devices in the World: Market Share by Neurostimulation Devices Revenue in 2021
Figure 35. Global Neurostimulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Neurostimulation Devices Sales Market Share by Type (2017-2028)
Figure 37. Global Neurostimulation Devices Revenue Market Share by Type (2017-2028)
Figure 38. Global Neurostimulation Devices Sales Market Share by Application (2017-2028)
Figure 39. Global Neurostimulation Devices Revenue Market Share by Application (2017-2028)
Figure 40. North America Neurostimulation Devices Sales Market Share by Type (2017-2028)
Figure 41. North America Neurostimulation Devices Revenue Market Share by Type (2017-2028)
Figure 42. North America Neurostimulation Devices Sales Market Share by Application (2017-2028)
Figure 43. North America Neurostimulation Devices Revenue Market Share by Application (2017-2028)
Figure 44. North America Neurostimulation Devices Sales Share by Country (2017-2028)
Figure 45. North America Neurostimulation Devices Revenue Share by Country (2017-2028)
Figure 46. U.S. Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Neurostimulation Devices Sales Market Share by Type (2017-2028)
Figure 49. Europe Neurostimulation Devices Revenue Market Share by Type (2017-2028)
Figure 50. Europe Neurostimulation Devices Sales Market Share by Application (2017-2028)
Figure 51. Europe Neurostimulation Devices Revenue Market Share by Application (2017-2028)
Figure 52. Europe Neurostimulation Devices Sales Share by Country (2017-2028)
Figure 53. Europe Neurostimulation Devices Revenue Share by Country (2017-2028)
Figure 54. Germany Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 55. France Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Neurostimulation Devices Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Neurostimulation Devices Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Neurostimulation Devices Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Neurostimulation Devices Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Neurostimulation Devices Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Neurostimulation Devices Revenue Share by Region (2017-2028)
Figure 65. China Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 68. India Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Neurostimulation Devices Sales Market Share by Type (2017-2028)
Figure 75. Latin America Neurostimulation Devices Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Neurostimulation Devices Sales Market Share by Application (2017-2028)
Figure 77. Latin America Neurostimulation Devices Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Neurostimulation Devices Sales Share by Country (2017-2028)
Figure 79. Latin America Neurostimulation Devices Revenue Share by Country (2017-2028)
Figure 80. Mexico Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Neurostimulation Devices Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Neurostimulation Devices Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Neurostimulation Devices Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Neurostimulation Devices Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Neurostimulation Devices Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Neurostimulation Devices Revenue Share by Country (2017-2028)
Figure 89. Turkey Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Neurostimulation Devices Revenue (2017-2028) & (US$ Million)
Figure 92. Neurostimulation Devices Value Chain
Figure 93. Neurostimulation Devices Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
$4900
$9800
HAVE A QUERY?
OUR CUSTOMER
